Table II.
Parameter1 | Group AKI (n = 21) | Group C (n = 41) | P-value |
---|---|---|---|
Blood morphology: | |||
WBC [× 109/l] | 6.9 ±1.8 | 7.5 ±1.7 | 0.216 |
PLT [× 109/l] | 220 ±65 | 246 ±49 | 0.080 |
RBC [× 1012/l] | 4.51 ±0.39 | 4.78 ±0.36 | 0.012* |
HBG [mM/l] | 8.46 ±0.72 | 9.07 ±0.57 | < 0.001* |
HCT [1/1] | 0.40 ±0.04 | 0.43 ±0.03 | 0.004* |
MCV [fl] | 89.0 ±5.1 | 90.1 ±4.4 | 0.390 |
MCH [fM] | 1.88 ±0.10 | 1.91 ±0.11 | 0.157 |
MCHC [mM/l] | 21.0 ±0.5 | 21.2 ±0.6 | 0.209 |
Biochemistry: | |||
Creatinine [mg/dl] | 0.89 ±0.21 | 0.90 ±0.16 | 0.928 |
eGFR [ml/min/1.73 m2] | 85.1 ±23.5 | 85.7 ±15.6 | 0.913 |
Continuous variables are expressed as mean ± standard deviation.
Statistically significant p-value, group AKI vs. group C.
eGFR – estimated glomerular filtration rate, HBG – hemoglobin concentration, HCT – hematocrit, MCH – mean corpuscular hemoglobin, MCHC – mean corpuscular hemoglobin concentration, MCV – mean corpuscular volume, PLT – platelet count, RBC – red blood cell count, WBC – white blood cell count.